Cargando…
Quinoxaline-substituted chalcones as new inhibitors of breast cancer resistance protein ABCG2: polyspecificity at B-ring position
A series of chalcones substituted by a quinoxaline unit at the B-ring were synthesized and tested as inhibitors of breast cancer resistance protein-mediated mitoxantrone efflux. These compounds appeared more efficient than analogs containing other B-ring substituents such as 2-naphthyl or 3,4-methyl...
Autores principales: | Winter, Evelyn, Gozzi, Gustavo Jabor, Chiaradia-Delatorre, Louise Domeneghini, Daflon-Yunes, Nathalia, Terreux, Raphael, Gauthier, Charlotte, Mascarello, Alessandra, Leal, Paulo César, Cadena, Silvia M, Yunes, Rosendo Augusto, Nunes, Ricardo José, Creczynski-Pasa, Tania Beatriz, Di Pietro, Attilio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4043709/ https://www.ncbi.nlm.nih.gov/pubmed/24920885 http://dx.doi.org/10.2147/DDDT.S56625 |
Ejemplares similares
-
New structure–activity relationships of chalcone inhibitors of breast cancer resistance protein: polyspecificity toward inhibition and critical substitutions against cytotoxicity
por: Rangel, Luciana Pereira, et al.
Publicado: (2013) -
In vitro and in vivo Effects of Free and Chalcones-Loaded Nanoemulsions: Insights and Challenges in Targeted Cancer Chemotherapies
por: Winter, Evelyn, et al.
Publicado: (2014) -
Phenolic indeno[1,2-b]indoles as ABCG2-selective potent and non-toxic inhibitors stimulating basal ATPase activity
por: Gozzi, Gustavo Jabor, et al.
Publicado: (2015) -
Discovery of Mycobacterium tuberculosis Protein Tyrosine Phosphatase B (PtpB) Inhibitors from Natural Products
por: Mascarello, Alessandra, et al.
Publicado: (2013) -
Pre-clinical evaluation of quinoxaline-derived chalcones in tuberculosis
por: Muradás, Thaís C., et al.
Publicado: (2018)